New treatment with granulocytecolony stimulating factor in diabetic foot ulceration;Fallbericht zur therapie mit granulozyten stimulierendem faktor beim diabetischen fuß

Hautarzt

Volumn 52, Issue 4, 2001, Pages 327-330

  Kreyden, O Ph ^a   Hafner, J ^a   Burg, G ^a   Nestle, F O ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Diabetic foot infection; G CSF; Granulocyte; Malum perforans

Indexed keywords

CIPROFLOXACIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ARTERIOSCLEROSIS; ARTICLE; CASE REPORT; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; HUMAN; INFECTION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PERIPHERAL NEUROPATHY; PHAGOCYTOSIS; POLYNEUROPATHY; RESPIRATORY BURST; RISK FACTOR; SKIN SENSITIVITY; VASCULAR DISEASE;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FILGRASTIM; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; NEUTROPHILS;

EID: 0035014111     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051316     Document Type: Article

References (11)

1. Neurotrophe Ulzera
2. Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats
3. Review: Granulocyte colony-stimulating factorrole and relationships in infectious diseases
4. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
5. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection
6. Presence of hypochlorite-modified proteins in human atherosderotic lesions
7. Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections
8. The diabetic foot. Soft tissue and bone infection
9. Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients
10. Der diabetische Fuß